Yishuo Wu

1.2k total citations
36 papers, 604 citations indexed

About

Yishuo Wu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Yishuo Wu has authored 36 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Yishuo Wu's work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Yishuo Wu is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Yishuo Wu collaborates with scholars based in China, United States and Hong Kong. Yishuo Wu's co-authors include Rong Na, Qiang Ding, Jianfeng Xu, Brian T. Helfand, Hongjie Yu, S. Lilly Zheng, Jianfeng Xu, William B. Isaacs, Ning Zhang and Zhuqing Shi and has published in prestigious journals such as PLoS ONE, European Urology and Advanced Science.

In The Last Decade

Yishuo Wu

36 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yishuo Wu China 14 368 231 151 113 108 36 604
Frances M. Martin United States 8 158 0.4× 215 0.9× 162 1.1× 15 0.1× 99 0.9× 13 460
Takeshi Namekawa Japan 10 160 0.4× 167 0.7× 115 0.8× 19 0.2× 94 0.9× 18 432
Naomi L. Sharma United Kingdom 7 305 0.8× 222 1.0× 73 0.5× 72 0.6× 119 1.1× 12 452
Steven Penegar United Kingdom 12 46 0.1× 260 1.1× 168 1.1× 132 1.2× 148 1.4× 20 552
P. Troncoso Chile 12 173 0.5× 135 0.6× 62 0.4× 21 0.2× 61 0.6× 32 402
Li Zuo China 13 118 0.3× 252 1.1× 93 0.6× 24 0.2× 127 1.2× 35 451
Tomoya Fukawa Japan 11 104 0.3× 164 0.7× 78 0.5× 16 0.1× 60 0.6× 62 392
Shaham Beg Saudi Arabia 15 98 0.3× 225 1.0× 204 1.4× 67 0.6× 114 1.1× 37 517
Daixing Hu China 15 182 0.5× 250 1.1× 116 0.8× 24 0.2× 169 1.6× 40 605
J Ronan United Kingdom 10 88 0.2× 74 0.3× 97 0.6× 41 0.4× 66 0.6× 13 326

Countries citing papers authored by Yishuo Wu

Since Specialization
Citations

This map shows the geographic impact of Yishuo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yishuo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yishuo Wu more than expected).

Fields of papers citing papers by Yishuo Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yishuo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yishuo Wu. The network helps show where Yishuo Wu may publish in the future.

Co-authorship network of co-authors of Yishuo Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yishuo Wu. A scholar is included among the top collaborators of Yishuo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yishuo Wu. Yishuo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Siteng, Encheng Zhang, Guangliang Jiang, et al.. (2022). Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma. Heliyon. 8(9). e10578–e10578. 3 indexed citations
2.
Jiang, Guangliang, Hui Wang, Da Huang, et al.. (2021). The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer. Frontiers in Oncology. 11. 752860–752860. 12 indexed citations
3.
Lin, Xiaoling, Yishuo Wu, Fang Liu, et al.. (2021). A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort. Frontiers in Oncology. 11. 753920–753920. 3 indexed citations
4.
Wu, Yishuo, Hongjie Yu, Shuwei Li, et al.. (2020). Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer. European Urology Oncology. 3(2). 224–230. 38 indexed citations
5.
Yu, Hongjie, Zhuqing Shi, Yishuo Wu, et al.. (2019). Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values. The Prostate. 79(10). 1099–1105. 14 indexed citations
6.
Shi, Zhuqing, Hongjie Yu, Yishuo Wu, et al.. (2019). Systematic evaluation of cancer‐specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts. Cancer Medicine. 8(6). 3196–3205. 18 indexed citations
7.
Zhang, Ning, Siteng Chen, Guangliang Jiang, et al.. (2019). The study on copy number alteration of clear cell renal cancer in Chinese population. Journal of Cancer. 11(1). 16–24. 5 indexed citations
8.
Zhang, Ning, Siteng Chen, Yishuo Wu, et al.. (2019). Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer. Journal of Cancer. 10(26). 6761–6766. 16 indexed citations
9.
Shi, Zhuqing, Hongjie Yu, Yishuo Wu, et al.. (2018). Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease. Clinical Genetics. 95(2). 302–309. 4 indexed citations
10.
Na, Rong, Yishuo Wu, Guangliang Jiang, et al.. (2018). Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis. British Journal of Urology. 122(5). 808–813. 11 indexed citations
11.
Na, Rong, Yishuo Wu, Xiaobo Wu, et al.. (2018). Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population. Asian Journal of Andrology. 20(4). 324–324. 15 indexed citations
12.
Wu, Yishuo, Haitao Chen, Guangliang Jiang, et al.. (2018). Genome-wide Association Study (GWAS) of Germline Copy Number Variations (CNVs) Reveal Genetic Risks of Prostate Cancer in Chinese population. Journal of Cancer. 9(5). 923–928. 12 indexed citations
13.
Wu, Yishuo, Guangliang Jiang, Ning Zhang, et al.. (2018). HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria. European Urology Focus. 6(2). 284–291. 37 indexed citations
14.
Carter, H. Ballentine, Brian T. Helfand, Mufaddal Mamawala, et al.. (2018). Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer. European Urology. 75(5). 743–749. 148 indexed citations
15.
Jiang, Guangliang, Qingfeng Hu, Hui Wang, et al.. (2018). A Cumulative Analysis of Current Evidence for Association between Expression of Epithelial-Mesenchymal Transition Markers and Clinicopathological Outcomes in Patients after Radical Prostatectomy.. PubMed. 48(1). 18–28. 1 indexed citations
16.
Zhang, Ning, Yishuo Wu, Jianqing Wang, et al.. (2016). The effect of discrepancy between radiologic size and pathologic tumor size in renal cell cancer. SpringerPlus. 5(1). 899–899. 4 indexed citations
17.
Xu, Jianfeng, Rong Na, Dingwei Ye, et al.. (2016). Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases. Asian Journal of Andrology. 18(4). 525–525. 10 indexed citations
18.
Na, Rong, Yishuo Wu, Ning Zhang, et al.. (2016). The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study. Asian Journal of Andrology. 18(6). 925–925. 15 indexed citations
19.
Liu, Shenghua, Hu Zhang, Yishuo Wu, et al.. (2015). The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population. PLoS ONE. 10(4). e0123617–e0123617. 28 indexed citations
20.
Wu, Yishuo, Limin Zhang, Rong Na, et al.. (2015). Plasma genistein and risk of prostate cancer in Chinese population. International Urology and Nephrology. 47(6). 965–970. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frances M. Martin Breakdown of academic impact, for papers by Takeshi Namekawa Breakdown of academic impact, for papers by Naomi L. Sharma Breakdown of academic impact, for papers by Steven Penegar Breakdown of academic impact, for papers by P. Troncoso Breakdown of academic impact, for papers by Li Zuo Breakdown of academic impact, for papers by Tomoya Fukawa Breakdown of academic impact, for papers by Shaham Beg Breakdown of academic impact, for papers by Daixing Hu Breakdown of academic impact, for papers by J Ronan
Rankless by CCL
2026